Pharmaceuticals

The U.S. trade deficit in goods and services widened to $77.6 billion in May as imports rose 3.3% and exports fell 3.2%. Increased demand for electronics, medicines, and AI-related technology drove higher imports, while the Trump administration’s tariffs and global supply chain disruptions from the Strait of Hormuz conflict failed to consistently reduce the deficit. New trade actions under Section 301 are being prepared to impose tariffs on countries restricting forced labor imports and those subsidizing domestic manufacturing.

Mexico aims to restart stalled trade negotiations with the UK, focusing on pharmaceuticals, financial services, and advanced manufacturing. Both nations already trade under a post-Brexit deal and share membership in the Comprehensive and Progressive Agreement for Trans-Pacific Partnership. A UK official confirmed talks are under discussion but has not set a timeline.

India’s envoy to China, Vikram Doraiswami, advocates for increased Indian exports to China, particularly in pharmaceuticals, which India is globally competitive in. The envoy suggests more Chinese investment benefits the broader relationship between the two countries.

PM Modi held summit talks with Japanese PM Takaichi. The discussion focused on enhancing cooperation in critical minerals and pharmaceuticals.

The EPA has stopped testing for microplastics in U.S. drinking water despite earlier commitments by EPA Administrator Lee Zeldin to prioritize such contaminants. The decision comes after Zeldin announced microplastics and pharmaceuticals as priority contaminants for testing earlier this year.

The US Trade Representative announced a new probe to determine if Germany is underpaying for pharmaceuticals. The investigation focuses on Germany's 'persistent underpayment' for drugs.

Indian Prime Minister Narendra Modi met with Venezuela's acting President Delcy Rodriguez to discuss expanding energy cooperation and investments in sectors like mining and pharmaceuticals. Venezuela has become India's third-largest crude oil supplier, as India seeks to diversify its energy sources amid global supply disruptions.

Pharmaceuticals have been detected in waterways globally, contributing to the rise of antibiotic-resistant superbugs that are no longer treatable. The article questions whether solutions exist to address this crisis.

Pharmaceuticals are found in waterways worldwide, contributing to antibiotic-resistant superbugs that no longer respond to treatment. The article questions whether solutions exist to address this crisis.

India's pharmaceutical supply chain to Africa is disrupted due to the closure of the Strait of Hormuz amid a war in Iran, affecting critical drug deliveries. The logistics corridor through Gulf states has been destabilized, impacting African patients reliant on Indian medications.

A 10p tablet is claimed to cure exhaustion and sleepless nights, supported by dozens of studies suggesting it helps users sleep longer without negative side effects. The article highlights its potential benefits for improving sleep quality and overall well-being.

Chiesi has agreed to acquire KalVista Pharmaceuticals for $1.9 billion, a significant move in the pharmaceutical industry. The deal aims to expand Chiesi's portfolio in innovative therapies.